![Xiao Dong Yang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Xiao Dong Yang
Fondateur chez
Apexigen America, Inc.
Profil
Xiao Dong Yang is the founder of three companies.
Abgenix, Inc. was founded in 1995, Apexigen America, Inc. was founded in 2010, and Apexigen, Inc. was also founded in 2010.
At Abgenix, Inc., he held the title of Scientist from 1995 to 2013.
At Apexigen America, Inc., he currently holds the titles of President, Chief Executive Officer & Director.
At Apexigen, Inc., he held the title of Chief Executive Officer & Director in 2023.
Dr. Yang's former jobs include Senior Director-Cancer Pharmacology at Amgen, Inc. in 2006, Member at Novartis Corp., VP-Research & Preclinical Development at Intradigm Corp., and Vice President-Preclinical Development at Silence Therapeutics Plc from 2009 to 2010.
Dr. Yang received a doctorate from the University of Bern and an undergraduate degree from Beijing University of Traditional Chinese Medicine.
Postes actifs de Xiao Dong Yang
| Sociétés | Poste | Début |
|---|---|---|
Apexigen America, Inc.
 Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Fondateur | 01/07/2010 |
Anciens postes connus de Xiao Dong Yang
| Sociétés | Poste | Fin |
|---|---|---|
| APEXIGEN, INC. | Fondateur | 23/08/2023 |
| SILENCE THERAPEUTICS PLC | Corporate Officer/Principal | 01/05/2010 |
| AMGEN INC. | Corporate Officer/Principal | 01/08/2006 |
Abgenix, Inc.
 Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Fondateur | - |
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | - |
Formation de Xiao Dong Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Abgenix, Inc.
Abgenix, Inc. BiotechnologyHealth Technology Develops therapeutic products | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
Intradigm Corp.
 Intradigm Corp. Pharmaceuticals: MajorHealth Technology Develops drugs and therapies | Health Technology |
Silence Therapeutics Plc
 Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing University of Traditional Chinese Medicine
 Beijing University of Traditional Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Apexigen America, Inc.
Apexigen America, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology | Health Technology |
Apexigen, Inc.
 Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer | Health Technology |
